EAM
Eventide Asset Management Portfolio holdings
AUM
$5.71B
This Quarter Return
+20.95%
1 Year Return
+51.18%
3 Year Return
+209.28%
5 Year Return
+283.63%
10 Year Return
+1,480.39%
AUM
$6.13B
AUM Growth
+$6.13B
(+10%)
Cap. Flow
-$282M
Cap. Flow
% of AUM
-4.6%
Top 10 Holdings %
Top 10 Hldgs %
24.72%
Holding
175
New
20
Increased
64
Reduced
41
Closed
23
Top Buys
| 1 |
Celldex Therapeutics
CLDX
|
$80.5M |
| 2 |
Zentalis Pharmaceuticals
ZNTL
|
$56.8M |
| 3 |
Xometry
XMTR
|
$47.8M |
| 4 |
Lexeo Therapeutics
LXEO
|
$40.3M |
| 5 |
monday.com
MNDY
|
$38.4M |
Top Sells
| 1 |
Korro Bio
KRRO
|
$146M |
| 2 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
$79.8M |
| 3 |
Exact Sciences
EXAS
|
$58.1M |
| 4 |
Ascendis Pharma
ASND
|
$49.7M |
| 5 |
KRTX
Karuna Therapeutics, Inc. Common Stock
KRTX
|
$47.4M |
Sector Composition
| 1 | Healthcare | 39.38% |
| 2 | Technology | 25.83% |
| 3 | Industrials | 16.87% |
| 4 | Consumer Discretionary | 8.76% |
| 5 | Energy | 2.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
EastGroup Properties
EGP
$8.87B
| $25.3M | 0.41% |
138,030
+71,576
| +108% | +$13.1M |
|
77
Keros Therapeutics
KROS
$651M
| $23.1M | 0.38% |
580,000
| – | – |
|
78
Privia Health
PRVA
$2.84B
| $23M | 0.38% |
1,000,000
| – | – |
|
|
79
Ascendis Pharma
ASND
$12.2B
| $22.8M | 0.37% |
180,857
-394,581
| -69% | -$49.7M |
|
|
IMGN
80
DELISTED
Immunogen Inc
IMGN
| $22.6M | 0.37% |
763,000
-537,000
| -41% | -$15.9M |
|
81
Steris
STE
$23.7B
| $21.7M | 0.35% |
98,873
-2,602
| -3% | -$572K |
|
82
MongoDB
MDB
$25.5B
| $21.7M | 0.35% |
52,994
+45,703
| +627% | +$18.7M |
|
83
Rollins
ROL
$27.3B
| $21.4M | 0.35% |
490,330
+2
| +0% | +$87 |
|
84
Repligen
RGEN
$6.77B
| $21.4M | 0.35% |
119,000
| – | – |
|
85
Autoliv
ALV
$9.64B
| $21.4M | 0.35% |
193,906
+185,456
| +2,195% | +$20.4M |
|
86
Novanta
NOVT
$4.03B
| $21.2M | 0.35% |
126,020
-8
| -0% | -$1.35K |
|
87
Houlihan Lokey
HLI
$13.8B
| $21M | 0.34% |
175,269
+25,637
| +17% | +$3.07M |
|
|
CERE
88
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
| $20.8M | 0.34% |
490,000
| – | – |
|
89
Insmed
INSM
$30.9B
| $19.7M | 0.32% |
635,185
| – | – |
|
90
Scholar Rock
SRRK
$3.27B
| $18.3M | 0.3% |
+972,733
| New | +$18.3M |
|
91
Element Solutions
ESI
$6.13B
| $18.1M | 0.3% |
782,325
+98,545
| +14% | +$2.28M |
|
92
Ultragenyx Pharmaceutical
RARE
$3.14B
| $17.2M | 0.28% |
359,000
| – | – |
|
93
Biohaven
BHVN
$1.78B
| $17.2M | 0.28% |
+401,101
| New | +$17.2M |
|
94
Diamondback Energy
FANG
$42.5B
| $17M | 0.28% |
109,621
-60,082
| -35% | -$9.32M |
|
95
Krystal Biotech
KRYS
$4.4B
| $16.9M | 0.28% |
+136,485
| New | +$16.9M |
|
96
Alnylam Pharmaceuticals
ALNY
$59.3B
| $16.7M | 0.27% |
+87,000
| New | +$16.7M |
|
97
Amylyx Pharmaceuticals
AMLX
$892M
| $16.4M | 0.27% |
1,116,837
| – | – |
|
98
MSCI
MSCI
$42.6B
| $16.4M | 0.27% |
29,024
-599
| -2% | -$339K |
|
99
CMS Energy
CMS
$21.3B
| $16.2M | 0.26% |
279,080
-52,278
| -16% | -$3.04M |
|
100
Prothena Corp
PRTA
$452M
| $16.2M | 0.26% |
445,155
| – | – |
|